consistent release characteristics across batches and during stability studies.

2. Scope

This SOP is applicable to Analytical Method Development (AMD) for IVRT of semi-solid topical cream formulations during product development, scale-up, validation, and post-approval changes.

3. Responsibilities

• Analytical Scientist: Sets up and operates IVRT apparatus, performs sampling and analysis.
• QC Analyst: Assists with membrane handling, receptor solution preparation, and documentation.
• QA Executive: Verifies method suitability, data integrity, and compliance with regulatory guidelines.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the scientific soundness, robustness, and reproducibility of the IVRT method as per regulatory expectations.

5. Procedure

5.1 Equipment and Materials

1. Vertical Diffusion Cell Apparatus (Franz Cell or equivalent)
2. Synthetic membrane (e.g., cellulose acetate, 0.45 µm)
3. Water bath with temperature control (maintained at 32 ± 0.5°C)
4. Receptor medium: Phosphate buffer or other validated solvent system
5. HPLC system with UV detector

5.2 Membrane Preparation

1. Soak membrane in receptor medium for 30 minutes prior to use.
2. Ensure membrane is free of tears, folds, or bubbles.

5.3 Sample Application

1. Weigh and apply a defined amount (e.g., 0.5 g) of cream formulation evenly over the membrane in the donor compartment.
2. Clamp the donor chamber over the receptor compartment containing 5–7 mL of receptor medium.

5.4 IVRT Protocol

1. Maintain receptor compartment at 32 ± 0.5°C throughout the test.
2. At specific intervals (e.g., 0.5, 1, 2, 3, 4, 6, and 8 hours), withdraw 0.5 mL sample and replace with fresh receptor medium.
3. Filter samples through 0.45 µm membrane before HPLC analysis.

5.5 HPLC Conditions (Example)

1. Column: C18, 150 mm × 4.6 mm, 5 µm
2. Mobile Phase: 70:30 (v/v) Methanol:Water with 0.1% acetic acid
3. Flow Rate: 1.0 mL/min
4. Detection: UV at 254 nm
5. Injection Volume: 20 µL

5.6 Calculation

1. Calculate cumulative amount of drug released (µg/cm²) at each time point using the formula:
   
   Q = (C × V) + Σ(C_i × V_r)
   
   Where C = concentration at time t, V = volume of receptor medium, C_i = concentrations of previous samples, V_r = sample volume.
2. Plot cumulative drug release vs. square root of time for release kinetics evaluation.

5.7 Acceptance Criteria

• Drug release should be consistent between replicate cells (% RSD ≤ 15%).
• Linear correlation with square root of time (R² ≥ 0.95) is expected.

5.8 Method Validation

1. Linearity: Over concentration range expected in samples
2. Precision: % RSD ≤ 5% for intra-day and inter-day replicates
3. Recovery: 98–102% from spiked receptor medium

6. Abbreviations

• IVRT: In-vitro Release Testing
• HPLC: High Performance Liquid Chromatography
• RSD: Relative Standard Deviation
• QA: Quality Assurance

7. Documents

1. IVRT Data Sheet – Annexure-1
2. Membrane Integrity Log – Annexure-2
3. IVRT Method Validation Report – Annexure-3

8. References

• FDA Guidance for Industry: Non-Sterile Semisolid Dosage Forms – Scale-Up and Postapproval Changes (SUPAC-SS)
• USP <1724>: Semisolid Drug Products – Performance Tests
• ICH Q2(R1): Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name	Dr. Kiran Mishra	Rohit Rajput	Sunita Reddy
Designation	Analytical Scientist	QA Reviewer	Head – AMD
Department	Analytical Method Development	QA	Analytical Method Development

11. Annexures

Annexure-1: IVRT Data Sheet

Time (hr)	Concentration (µg/mL)	Cumulative Release (µg/cm²)
1	8.2	25.6
2	15.1	49.5
4	28.4	92.6

Annexure-2: Membrane Integrity Log

Membrane Lot No.	Type	Pre-Test Soak Time	Status	Checked By
CA-0525	Cellulose Acetate	30 mins	Pass	Rohit Rajput

Annexure-3: IVRT Method Validation Report

IVRT method for cream formulation CR-253 was validated for accuracy (recoveries 98.7–101.8%), precision (% RSD = 1.9%), and robustness (temperature and flow rate variations). Method suitable for routine release and comparative batch evaluation.

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
21/05/2025	2.0	Revised temperature tolerance and added validation section	Annual Review	Sunita Reddy
20/01/2022	1.0	Initial SOP Release	New SOP	QA Head